051-Anaesthesia, Pharmacology, Intensive Care and Emergency

396 Pages·2012·2.7 MB·English

APICE 23

Antonino Gullo (Ed.)
A P
naesthesia, harmacology,
C
Intensive are
and Emergency Medicine
A.P.I.C.E.
Proceedings of the
23rd Postgraduate Course in Critical Care Medicine
Catania, Italy - November 5-7, 2010
Editor
Antonino Gullo
Department and School of Anaesthesia and
Intensive Care, Catania University-Hospital
Catania, Italy
ISBN 978-88-470-2013-9 e-ISBN 978-88-470-2014-6
DOI 10.1007/978-88-470-2014-6
Springer Milan Dordrecht Heidelberg London New York
Library of Congress Control Number: 2011923540
© Springer-Verlag Italia 2011
This work is subject to copyright. All rights are reserved, whether the whole or part of the material is
concerned, speci(cid:2) cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting,
reproduction on micro(cid:2) lm or in any other way, and storage in data banks. Duplication of this publication
or parts thereof is permitted only under the provisions of the Italian Copyright Law in its current version,
and permission for use must always be obtained from Springer. Violations are liable to prosecution under
the Italian Copyright Law.
The use of general descriptive names, registered names, trademarks, etc. in this publication does
not imply, even in the absence of a speci(cid:2) c statement, that such names are exempt from the relevant
protective laws and regulations and therefore free for general use.
Product liability: The publishers cannot guarantee the accuracy of any information about dosage and
application contained in this book. In every individual case the user must check such information by
consulting the relevant literature.
9 8 7 6 5 4 3 2 1
Cover design: Simona Colombo, Milan, Italy
Typesetting: Graphostudio, Milan, Italy
Springer-Verlag Italia S.r.l. – Via Decembrio 28 – I-20137 Milan
Springer is a part of Springer Science+Business Media (www.springer.com)
Contents
Part I Continuing Medical Education
1 Can I Think what I Read? ................................................................................ 1
Philip D. Lumb
Part II Clinical Pharmacology
2 Pharmacological Manipulation in ICU ........................................................... 9
Daniel De Backer, Katia Donadello and Sabino Scolletta
2.1 Effects of Fluids ..................................................................................... 10
2.2 Effects of Red Blood Cell Transfusions ................................................. 11
2.3 Effects of Inotropic Agents ..................................................................... 11
2.4 Effects of Vasopressor Agents ................................................................ 11
2.5 A Place for Vasodilatory Agents? ........................................................... 12
2.6 Effects of Agents with Anticoagulant Properties .................................... 13
2.7 Conclusions ............................................................................................ 13
References ........................................................................................................... 13
Part III Kidney
3 Renal Injury ...................................................................................................... 19
Vladimir Gašparovi(cid:254), Ivan Gornik
3.1 Introduction ............................................................................................ 19
3.2 De(cid:2) nition ................................................................................................ 19
3.3 Epidemiology ......................................................................................... 20
3.4 Aetiology ................................................................................................ 20
v
vi Contents
3.5 Differences Between Acute and Chronic Kidney Injury ........................ 20
3.6 Prerenal Acute Kidney Injury ................................................................. 21
3.6.1 Aetiology of Prerenal AKI...................................................................... 21
3.6.2 Pathophysiology of Prerenal AKI ........................................................... 21
3.7 Intrinsic Acute Kidney Injury ................................................................. 22
3.7.1 Aetiology ................................................................................................ 22
3.8 Pathogenesis of Acute Intrinsic Kidney Injury ....................................... 23
3.9 Postrenal Acute Kidney Injury ............................................................... 23
3.10 Clinical Presentation of Acute Kidney Injury ........................................ 23
3.11 Diagnostic Algorithm and Differential Diagnosis .................................. 25
3.11.1 Postrenal AKI ......................................................................................... 25
3.11.2 Prerenal or Intrinsic Renal AKI? ............................................................ 25
3.12 Treatment of Acute Kidney Injury .......................................................... 26
3.12.1 Fluid Balance .......................................................................................... 26
3.12.2 Hyperkalaemia ........................................................................................ 26
3.12.3 Metabolic Acidosis ................................................................................. 27
3.12.4 Diet ......................................................................................................... 27
3.12.5 Indications for Haemodialysis ................................................................ 27
3.13 Prognosis ................................................................................................ 28
3.14 Prevention ............................................................................................... 28
Further Reading .................................................................................................. 29
Part IV Ventilation: Adult and Paediatric
4 Respiratory Mechanics: Principles, Utility and Advances ............................ 33
Alysson R. Carvalho, Walter A. Zin
4.1 Introduction ............................................................................................ 33
4.2 Principles ................................................................................................ 34
4.2.1 Pleural Pressure ...................................................................................... 34
4.2.2 Elastic Recoil of the Lungs..................................................................... 35
4.2.3 Elastic Recoil of the Chest Wall ............................................................. 38
4.2.4 Elastic Recoil of the Respiratory System ............................................... 39
4.3 Resistive Properties ................................................................................ 40
4.3.1 Pulmonary Resistance ............................................................................ 40
4.3.2 Chest-wall Resistance ............................................................................. 42
4.3.3 Respiratory System Resistance............................................................... 42
4.4 Utility and Advances .............................................................................. 42
References ........................................................................................................... 44
5 Capnometry/capnography in Prehospital Cardiopulmonary Resuscitation 47
Štefek Grmec, Katia Lah and Štefan Mally
5.1 Introduction ............................................................................................ 47
5.2 Physiology and Clinical Applications of Capnography.......................... 47
Contents vii
5.3 Research of Capnometry/capnography in the Centre
for Emergency Medicine, Maribor ......................................................... 50
5.3.1 Capnography/capnometry and Veri(cid:2) cation of Endotracheal Tube
Placement ............................................................................................... 50
5.4 Capnography in Cardiac Arrest and Cardiopulmonary Resuscitation .... 52
5.5 Conclusions ............................................................................................ 54
References ........................................................................................................... 54
6 Weaning from Mechanical Ventilation ............................................................ 57
Irene Cortés Puch, Andrés Esteban
6.1 Introduction ............................................................................................ 57
6.2 Assessing Readiness for Weaning .......................................................... 58
6.2.1 Predictors of Adequate Spontaneous Breathing ..................................... 59
6.3 Spontaneous Breathing Trials ................................................................. 60
6.3.1 Duration of the Spontaneous Breathing Trial ......................................... 60
6.3.2 Criteria to De(cid:2) ne SBT Tolerance/Success ............................................. 61
6.4 Failure of the Spontaneous Breathing Trial ............................................ 61
6.4.1 Causes of Weaning Failure ..................................................................... 61
6.4.2 Management of Patients who Fail Spontaneous Breathing Tests ........... 62
6.4.3 Withdrawal of Ventilatory Support ......................................................... 63
6.5 Extubation............................................................................................... 65
6.5.1 Risks Related to Reintubation ................................................................ 66
6.6 The Role of Noninvasive Positive Pressure Ventilation ......................... 66
6.6.1 Noninvasive Positive Pressure Ventilation as a Weaning Method ......... 67
6.6.2 Noninvasive Ventilation for Respiratory Failure after Extubation ......... 68
6.6.3 Noninvasive Positive-Pressure Ventilation for Preventing Respiratory
Failure after Extubation .......................................................................... 69
6.7 Management of Sedation and Weaning .................................................. 70
6.8 Weaning in Special Populations ............................................................. 71
6.8.1 Critical-Illness Polyneuropathy (CIP) and Weaning .............................. 71
6.8.2 Neurological and Neurosurgical Patients ............................................... 72
6.8.3 Chronic Obstructive Pulmonary Disease................................................ 72
References ........................................................................................................... 73
7 Ventilatory Strategies in Acute Lung Injury .................................................. 77
Edoardo Calderini, Sara Sher and Eleonora Allegritti
7.1 Introduction ............................................................................................ 77
7.2 Ventilatory Support ................................................................................. 78
7.2.1 Ventilator-induced Lung Injury .............................................................. 78
7.2.2 Prone Positioning ................................................................................... 80
7.2.3 Noninvasive Respiratory Support........................................................... 80
7.3 Conclusions ............................................................................................ 84
References ........................................................................................................... 84
viii Contents
8 Mechanical Ventilation Beyond the PICU ...................................................... 89
Giancarlo Ottonello, Alessia Franceschi
8.1 Introduction ............................................................................................ 89
8.2 The Extent of the Problem ...................................................................... 89
8.3 Patient Care: A Multisystemic Approach ............................................... 90
8.3.1 Mechanical Ventilation ........................................................................... 90
8.4 Prescribing Home Ventilation: Certi(cid:2) cation and Documentation .......... 94
8.4.1 Attribution of Disability ......................................................................... 94
8.4.2 Handicapped Certi(cid:2) cation ...................................................................... 94
8.4.3 Rare Disease Certi(cid:2) cation ...................................................................... 94
8.4.4 School Attendance .................................................................................. 95
8.4.5 Worker Bene(cid:2) ts ...................................................................................... 95
8.5 Caregiver Training .................................................................................. 95
8.6 Follow-up and Emergency Admissions .................................................. 96
8.7 Ethics ...................................................................................................... 96
8.8 Conclusions ............................................................................................ 97
References ........................................................................................................... 97
Part V Cardiovascular Monitoring
9 The Nex(cid:2) n Monitor – A Totally Non-Invasive Cardiac Output Monitor .................. 103
Azriel Perel, Wilbert Wesselink and Jos Settels
9.1 Introduction ............................................................................................ 103
9.2 Principles of CCO Measurement by the Nex(cid:2) n HD .............................. 104
9.2.1 Continuous Measurement of Finger BP ................................................. 104
9.2.2 Transformation of the Finger BP Curve into a Brachial Artery Waveform 105
9.2.3 Calculating CCO from Brachial Arterial Pressure Waveform ................ 105
9.3 Validation of the Nex(cid:2) n HD ................................................................... 106
9.4 Clinical Applications .............................................................................. 106
References ........................................................................................................... 107
10 Doppler Echocardiography in ICU Patients: Does It Improve Outcome? .. 109
Jan Poelaert
10.1 Introduction ............................................................................................ 109
10.2 Doppler Echocardiography ..................................................................... 109
10.3 Echo-Doppler Diagnostic Tools ............................................................. 110
10.4 Immediate Bedside Haemodynamic Information ................................... 110
10.5 Right Ventricle ........................................................................................ 112
10.6 Preload and Fluid Responsiveness ......................................................... 113
10.7 Conclusions ............................................................................................ 113
References ........................................................................................................... 114
Contents ix
Part VI Management of Cardiac Arrest
11 Mild Therapeutic Hypothermia after Cardiac Arrest ................................... 119
Tommaso Pellis, Vincenzo Mione and Willy P. Mercante
11.1 Introduction ............................................................................................ 119
11.2 Mechanisms of Neuroprotection ............................................................ 119
11.3 Clinical Relevance .................................................................................. 120
11.3.1 Randomised Clinical Trials .................................................................... 120
11.3.2 Nonrandomised Clinical Trials ............................................................... 121
11.4 Complications of Mild Therapeutic Hypothermia ................................. 121
11.4.1 Changes in the Immune System ............................................................. 122
11.4.2 Effects on Coagulation ........................................................................... 122
11.4.3 Cardiovascular and Haemodynamic Effects .......................................... 122
11.4.4 Drug Metabolism .................................................................................... 123
11.5 Conclusions ............................................................................................ 123
References ........................................................................................................... 124
12 Nasopharyngeal Cooling During Cardiopulmonary Resuscitation ............. 129
Francesco Fumagalli, Giuseppe Ristagno
12.1 Introduction ............................................................................................ 129
12.2 Therapeutic Hypothermia Following Resuscitation from Cardiac Arrest .. 129
12.3 Nasopharyngeal Cooling During CPR ................................................... 131
12.4 Conclusions ............................................................................................ 135
References ........................................................................................................... 135
13 Amplitude Spectrum Area as a Predictor of Successful De(cid:2) brillation ........ 141
Giuseppe Ristagno, Yongqin Li, Antonino Gullo and Joe Bisera
13.1 Introduction ............................................................................................ 141
13.2 Monitoring Effectiveness of Chest Compression and Predicting
Return of Circulation .............................................................................. 142
13.3 Analyses of ECG Features During Ventricular Fibrillation and CPR .... 143
13.4 Amplitude Spectrum Area (AMSA) as Predictor of Successful
De(cid:2) brillation ........................................................................................... 145
13.5 Applicability of AMSA to the Clinical Scenario .................................... 150
13.6 Conclusions ............................................................................................ 153
References ........................................................................................................... 154
Part VII Advances in Experimental and Clinical Research
14 Physiopathology and Severity of Post-Resuscitation Myocardial Dysfunction:
Effects of Sodium-Hydrogen Exchanger Isoform-1 (NHE-1) Inhibitors and
Erythropoietin ................................................................................................... 163
Raúl J. Gazmuri, Iyad M. Ayoub and Jeejabai Radhakrishnan